Genetic and pharmacological manipulations of the CB1 receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice

Synapse

Volumn 62, Issue 8, 2008, Pages 574-581

  Vinod, K Yaragudri ^a,b,c   Yalamanchili, Ratnakumar ^a   Thanos, Panayotis K ^d,e   Vadasz, Csaba ^a,c   Cooper, Thomas B ^a,b,c,f   Volkow, Nora D ^e   Hungund, Basalingappa L ^a,b,f  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^f Columbia University ^*  (United States)

Author keywords

Alcohol; Anandamide; CB1 receptor; Endocannabinoid; G protein; Striatum

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ALCOHOL; CANNABINOID 1 RECEPTOR; DEXANABINOL; ENDOCANNABINOID; GUANINE NUCLEOTIDE BINDING PROTEIN; RIMONABANT;

ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG ALCOHOL INTERACTION; GENE DELETION; GENETIC ANALYSIS; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ALCOHOLISM; ANALGESICS; ANIMALS; BINDING, COMPETITIVE; BRAIN; CYCLOHEXANOLS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTORS, G-PROTEIN-COUPLED; SPECIES SPECIFICITY;

EID: 46749136095     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20533     Document Type: Article

References (51)

1. 35S]guanosine triphosphate gammas binding in the brain of C57BL/6 and DBA/2 mice. J Neurosci Res 64:429-436.
2. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. 2000. Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochem Biophys Acta 1535:78-86.
3. Chaperon F, Thiebot MH. 1999. Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243-281.
4. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM. 2007. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 27:791-795.
5. Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G, Carai MM, Gessa L. 2002. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology 159:181-187.
6. Colombo G, Orru A, Lai P, Cabras C, Maccioni P, Rubio M, Gessa GL, Carai MA. 2007. The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: Preclinical evidence. Mol Neurobiol 36:102-112.
7. De Witte P, Pinto E, Ansseau M, Verbanck P. 2003. Alcohol and withdrawal: From animal research to clinical issues. Neurosci Biobehav Rev 27:189-197.
8. Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR. 2000. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 76: 2434-1444.
9. George SR, Fan T, Ng GY, Jung SY, O'Dowd BF, Naranjo CA. 1995. Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: Reversal by increasing synaptic dopamine. J Pharmacol Exp Ther 273:373-379.
10. Gessa GL, Melis M, Muntoni AL, Diana M. 1998. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39-44.
11. Gessa GL, Serra S, Vacca G, Carai MA, Colombo G. 2005. Suppressing effect of the cannabinoid CB1 receptor antagonist. SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 40:46-53.
12. Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA. 2000a. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73-81.
13. Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA. 2002b. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels. Drug Alcohol Depend 66:77-84.
14. Hansen HHI, Azcoitia S, Pons J, Romero LM, Garcia-Segura JA, Ramos HS, Hansen J, Fernandez-Ruiz JJ. 2002. Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity. J Neurochem 82:154-158.
15. Heath AC, Whitfield JB, Madden PA, Bucholz KK, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DB, Martin NG. 2001. Towards a molecular epidemiology of alcohol dependence: Analysing the interplay of genetic and environmental risk factors. Br J Psychiatry 40:33-40.
16. Hospital F, Chevalet C, Mulsant P. 1992. Using markers in gene introgression breeding programs. Genetics 132:1199-1210.
17. Howlett AC. 2005. Cannabinoid receptor signaling. Handbook Exp Pharmacol 168:53-79.
18. Hungund BL, Szakall I, Adam A, Basavarajappa B, Vadasz C. 2003. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary ethanol consumption and lack ethanol-induced dopamine release in the nucleus accumbens. J Neurochem 84: 698-704.
19. Ishiguro H, Iwasaki S, Teasenfitz L, Higuchi S, Horiuchi Y, Saito T, Arinami T, Onaivi ES. 2007. Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenom J 7:380-385.
20. Kelai S, Hanoun N, Aufrere G, Beauge F, Hamon M, Lanfumey L. 2006. Cannabinoid-serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice. J Neurochem 99:308-20.
21. Kliethermes CL, Cronise K, Crabbe JC. 2004. Anxiety-like behavior in mice in two apparatuses during withdrawal from chronic ethanol vapor inhalation. Alcoholism Clin Exp Res 28:1012-1019.
22. Lallemand F, Soubrie PH De Witte PH. 2001. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcoholism Clin Exp Res 25:1317-1323.
23. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M. 1999. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401-404.
24. Mas-Nieto M, Pommier B, Tzavara ET, Caneparo A, Da Nascimento S, Le Fur G, Roques BP, Noble F. 2001. Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: Evaluation of the interest in pharmacotherapy of opioid addiction. Br J Pharmacol 132:1809-1816.
25. Misra K, Pandey SC. 2003. Differences in basal levels of CREB and NPY in nucleus accumbens regions between C57BL/6 and DBA/2 mice differing in inborn alcohol drinking behavior. J Neurosci Res 74:967-975.
26. Misra K, Pandey SC. 2006. The decreased cyclic-AMP dependent-protein kinase a function in the nucleus accumbens: A role in alcohol drinking but not in anxiety-like behaviors in rats. Neuropsychopharmacology 31:1406-1419.
27. Naassila M, Pierrefiche O, Ledent C, Daoust M. 2004. Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacol 46:243-253.
28. Nowak KL, Vinod KY, Hungund BL. 2006. Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol. Alcohol Alcohol 41:24-32.
29. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR. 2006. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514-536.
30. Ortiz S, Oliva JM, Perez-Rial S, Palomo T, Manzanares J. 2004. Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 39:88-92.
31. Pandey SC, Zhang H, Roy A, Misra K. 2006. Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J Neurosci 26:8320-8331.
32. Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A. 2003. A critical role for the cannabinoid CB1 receptors in ethanol dependence and stress-stimulated ethanol drinking. J Neurosci 23:2453-2458.
33. Rawls SM, Cabassa J, Geller EB, Adler MW. 2002. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4- morpholinylmethyl)-1-(1-naphthalenylcarboyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one] -induced hypothermia. J Pharmacol Exp Ther 301:963-968.
34. Ripley TL, Dunworth SJ, Stephens DN. 2002. Effect of CGP39551 administration on the kindling of ethanol-withdrawal seizures. Psychopharmacology 163:157-165.
35. Schlicker E, Kathmann M. 2001. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572.
36. Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B, Rommelspacher H, Hoehe MR. 2002. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65:221-224.
37. Solinas M, Justinova Z, Goldberg SR, Tanda G. 2006. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J Neurochem 98:408-419.
38. Sommer C, Schumacher M, Berger C, Kuhnert K, Muller HD, Schwab SSchabitz WR. 2006. Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Acta Neuropathol 112:277-286.
39. Sugiura T, Kishimoto S, Oka S, Gokoh M. 2006. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 45:405-446.
40. Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND. 2005. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 164:206-213.
41. Vadasz C, Saito M, Gyetvai B, Mikics E, Vadasz C II. 2000. Scanning of five chromosomes for alcohol consumption loci. Alcohol 22:25-34.
42. van der Stelt M, Di Marzo V. 2005. Anandamide as an intracellular messenger regulating ion channel activity. Prostagland Other Lipid Mediat 77:111-122.
43. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA. 2005. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329-332.
44. Vinod KY, Hungund BL. 2006. Cannabinoid-1 receptor: A novel target for the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 10:203-210.
45. Vinod KY, Yalamanchili R, Xie S, Cooper TB, Hungund BL. 2006. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem Int 49:619-625.
46. Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G. 2003. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100:1393-1398.
47. Warnault V, Houchi H, Barbier E, Pierrefiche O, Vilpoux C, Ledent C, Daoust M, Naassila M. 2007. The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABA(A) receptors after chronic ethanol exposure. J Neurochem 102:741-752.
48. Weiss F, Lorang MT, Bloom FE, Koob GF. 1993. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: Genetic and motivational determinants. J Pharmacol Exp Ther 267:250-258.
49. Wiley JL, Razdan RK, Martin BR. 2006. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sci 80:24-35.
50. Wise LE, Shelton CC, Cravatt BF, Martin BR, Lichtman AH. 2007. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. Eur J Pharmacol 557:44-48.
51. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. 1999. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785.